Balversa

Balversa (Erdafitinib) is an oral medication used to treat specific types of cancer. This advanced therapy targets genetic mutations to help manage disease progression.

Balversa is primarily used in the treatment of certain cancers with specific genetic markers. It works by targeting these mutations to slow down or stop cancer cell growth. Patients often wonder, 'What is Balversa used for?' This medication is designed for those who have particular genetic alterations that make them suitable candidates for this treatment.

Common effects of Balversa may include fatigue, nausea, and changes in appetite. Some users also report mild skin reactions. These effects can vary widely among individuals, and not everyone will experience them.

Balversa should be handled with care, following the guidance of a healthcare professional. It is important to store this medication properly and to avoid missing doses. Patients should also be aware of potential interactions with other medications.

Balversa may interact with certain other medications, including those that affect liver enzymes. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and other substances may also impact the effectiveness of Balversa.